Vertero Unveils New Strategic Direction Focused on Breaking Barriers in Neurodegenerative Diseases
Vertero Unveils New Strategic Direction Focused on Breaking Barriers in Neurodegenerative Diseases GlobeNewswire October 21, 2025 Formerly Axial Therapeutics, Vertero is rapidly advancing a novel approach to address peripheral drivers of challenging neurodegenerative diseases Lead candidate VT-5006 is a first-in-class small molecule designed to precisely engage a validated target in the GI wall to slow […]